Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Amolyt Pharma Announces $138 Million Series C Financing
Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related […]
AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology Targets
AbbVie and Immunome, a clinical-stage biopharmaceutical company that utilizes its human memory B cell platform […]
Annovis Bio Announces New Appointments to Strengthen Its Senior Leadership Team
Annovis Bio, a clinical-stage drug platform company addressing neurodegenerative diseases, has announced key additions to […]
Lyndra Therapeutics Announces New Board Members and Chief Technology Officer
Lyndra Therapeutics, a clinical-stage biopharmaceutical company pioneering long-acting oral therapies, today announced the appointment of […]
Immune-Onc Therapeutics Announces Close of Series B Extension Financing, Bringing Total Round to $131 Million
Immune-Onc Therapeutics, a private, clinical-stage cancer immunotherapy company developing novel biotherapeutics targeting myeloid checkpoints has […]
Acorda Therapeutics Announces New Agreement with Catalent for Long-Term Global Supply of INBRIJA®
Acorda Therapeutics has announced that on December 31, 2022 it entered into a new long-term […]
New Partnership to Boost Research into Vaccines for Cancer
Trials into vaccines for cancer and wider diseases will accelerate after the government reached a […]
HighTide Therapeutics Raises $107 Million in Series Financing to Advance Innovative Pipeline and Business Collaborations
HighTide Therapeutics, a globally integrated clinical-stage biopharmaceutical company developing novel multifunctional therapies for metabolic and […]
Onc.AI Raises $25 Million Series A Financing Co-Led by MassMutual and Action Potential Venture Capital
Onc.AI, a medical technology company developing a novel digital clinical management solution focused on immuno-oncology, […]
Orbit Discovery and SanegeneBio Collaborate to Identify Targeting Peptides for RNAi Drugs
Orbit Discovery, a leader in the discovery of therapeutic peptide hits, has announced it has […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more